Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesBeginning Cash BalanceCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

BioCorRx (BICX) Change in Account Payables (2016)

BioCorRx's Change in Account Payables history spans 7 years, with the latest figure at $328890.0 for Q4 2016.

  • For Q4 2016, Change in Account Payables rose 261.08% year-over-year to $328890.0; the TTM value through Dec 2016 reached -$42740.0, down 108.89%, while the annual FY2016 figure was -$42740.0, 108.89% down from the prior year.
  • Change in Account Payables for Q4 2016 was $328890.0 at BioCorRx, up from -$126365.0 in the prior quarter.
  • Across five years, Change in Account Payables topped out at $328890.0 in Q4 2016 and bottomed at -$250738.0 in Q2 2016.
  • The 5-year median for Change in Account Payables is $65519.0 (2012), against an average of $47209.6.
  • The largest YoY upside for Change in Account Payables was 442.8% in 2012 against a maximum downside of 989.2% in 2012.
  • A 5-year view of Change in Account Payables shows it stood at $44323.0 in 2012, then skyrocketed by 191.1% to $129026.0 in 2013, then grew by 15.44% to $148942.0 in 2014, then crashed by 38.85% to $91085.0 in 2015, then skyrocketed by 261.08% to $328890.0 in 2016.
  • Per Business Quant, the three most recent readings for BICX's Change in Account Payables are $328890.0 (Q4 2016), -$126365.0 (Q3 2016), and -$250738.0 (Q2 2016).